These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 2901849

  • 21. Effect of the peroxisome proliferator ciprofibrate on hepatic DNA synthesis and hepatic composition following partial hepatectomy in rats.
    Srinivasan SR, Chow CK, Glauert HP.
    Toxicology; 1990 Jun; 62(3):321-32. PubMed ID: 2389247
    [Abstract] [Full Text] [Related]

  • 22. Peroxisome proliferator-induced hepatocarcinogenesis: histochemical analysis of ciprofibrate-induced preneoplastic and neoplastic lesions for gamma-glutamyl transpeptidase activity.
    Rao MS, Subbarao V, Reddy JK.
    J Natl Cancer Inst; 1986 Oct; 77(4):951-6. PubMed ID: 2876121
    [Abstract] [Full Text] [Related]

  • 23. Effect of phenobarbital and the peroxisome proliferator ciprofibrate on gamma-Glutamyltranspeptidase activity and leukotriene C4 concentration in cultured rat hepatocytes.
    Hong JT, Wilson MW, Glauert HP.
    J Biochem Toxicol; 1995 Oct; 10(5):239-243. PubMed ID: 8847705
    [Abstract] [Full Text] [Related]

  • 24. Flow cytometric analysis of neoplastic nodules and hepatocellular carcinomas induced by ciprofibrate in the rat.
    Goolsby CL, Rao MS.
    Br J Cancer; 1996 Jan; 73(2):197-202. PubMed ID: 8546906
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Peroxisome proliferation and beta-oxidation in Fao and MH1C1 rat hepatoma cells, HepG2 human hepatoblastoma cells and cultured human hepatocytes: effect of ciprofibrate.
    Duclos S, Bride J, Ramirez LC, Bournot P.
    Eur J Cell Biol; 1997 Apr; 72(4):314-23. PubMed ID: 9127731
    [Abstract] [Full Text] [Related]

  • 34. Analysis of peroxisome proliferator-induced preneoplastic and neoplastic lesions of rat liver for placental form of glutathione S-transferase and gamma-glutamyltranspeptidase.
    Rao MS, Tatematsu M, Subbarao V, Ito N, Reddy JK.
    Cancer Res; 1986 Oct; 46(10):5287-90. PubMed ID: 2875789
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Changes in drug-metabolizing enzymes of rats in ciprofibrate-induced hepatic nodules.
    Roomi MW, Farber E, Parke DV.
    Xenobiotica; 1997 Sep; 27(9):951-60. PubMed ID: 9381735
    [Abstract] [Full Text] [Related]

  • 38. An in vitro demonstration of peroxisome proliferation and increase in peroxisomal beta-oxidation system mRNAs in cultured rat hepatocytes treated with ciprofibrate.
    Thangada S, Alvares K, Mangino M, Usman MI, Rao MS, Reddy JK.
    FEBS Lett; 1989 Jul 03; 250(2):205-10. PubMed ID: 2753129
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.